Fulcrum Therapeutics, Inc. (FULC)

Fulcrum Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	42.59	58.21	25.56	35.1	35.41	57.05
Short-Term Investments	171.52	182.81	210.66	167.82	182.75	55.86
Cash & Short-Term Investments	214.11	241.02	236.22	202.92	218.16	112.91
Cash Growth	-21.79%	2.03%	16.41%	-6.99%	93.21%	16.75%
Accounts Receivable	-	2.1	0.54	0.23	3.64	2.53
Other Receivables	1.33	1.25	1.71	0.85	0.47	0.18
Receivables	1.33	3.34	2.25	1.08	4.11	2.71
Prepaid Expenses	3.93	5.56	3.73	3.52	3.73	3.82
Other Current Assets	-	-	-	-	-	0.07
Total Current Assets	219.37	249.92	242.2	207.52	226	119.51
Property, Plant & Equipment	8.25	9.58	12.39	15.97	7.37	8.4
Other Long-Term Assets	1.22	1.21	3.1	3.2	1.63	1.67
Total Assets	228.84	260.72	257.69	226.69	235	129.58
Accounts Payable	1.75	1.16	2.76	3.64	4.79	4.08
Accrued Expenses	4.77	7.23	8.33	9.45	9.16	7.21
Current Portion of Leases	2.29	2.19	2.19	2.6	-	0.02
Current Unearned Revenue	-	-	-	0.93	4.71	14.91
Other Current Liabilities	0.17	0.46	0.4	0.11	0.54	0.51
Total Current Liabilities	8.99	11.04	13.68	16.73	19.2	26.73
Long-Term Leases	5.28	6.44	8.63	10.82	-	-
Long-Term Unearned Revenue	-	-	-	-	-	2.97
Other Long-Term Liabilities	0.2	0.2	0.2	0.2	4.26	4.7
Total Liabilities	14.46	17.68	22.5	27.74	23.46	34.4
Common Stock	0.05	0.05	0.06	0.05	0.04	0.03
Additional Paid-In Capital	768.59	762.25	744.94	612.03	514.36	316.78
Retained Earnings	-554.35	-519.4	-509.67	-412.34	-302.47	-221.62
Comprehensive Income & Other	0.08	0.13	-0.14	-0.8	-0.4	-0
Total Common Equity	214.38	243.03	235.19	198.94	211.54	95.18
Shareholders' Equity	214.38	243.03	235.19	198.94	211.54	95.18
Total Liabilities & Equity	228.84	260.72	257.69	226.69	235	129.58
Total Debt	7.57	8.63	10.82	13.42	-	0.02
Net Cash (Debt)	206.54	232.39	225.4	189.5	218.16	112.9
Net Cash Growth	-21.80%	3.10%	18.95%	-13.14%	93.24%	16.79%
Net Cash Per Share	3.32	3.75	3.68	4.21	6.17	4.45
Filing Date Shares Outstanding	54.09	53.98	61.94	61.76	40.63	32.55
Total Common Shares Outstanding	54.09	53.97	61.92	52.1	40.63	27.94
Working Capital	210.39	238.88	228.52	190.79	206.8	92.79
Book Value Per Share	3.96	4.50	3.80	3.82	5.21	3.41
Tangible Book Value	214.38	243.03	235.19	198.94	211.54	95.18
Tangible Book Value Per Share	3.96	4.50	3.80	3.82	5.21	3.41
Machinery	10.9	10.84	10.68	10.24	9.15	7.84
Construction In Progress	-	-	-	0.03	-	0.26
Leasehold Improvements	7.12	7.12	7.1	7.1	6.29	6.21

Updated Jul 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q